Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathophysiology of migraine chronification.

Literature DB >> 20464576

Pathophysiology of migraine chronification.

Abstract

Migraine is a prevalent, disabling, undiagnosed and undertreated disease in neurological practice. It is a chronic, recurrent disorder with episodic manifestations that are progressive in some individuals with clinical, physiological and anatomical bases. Progression may be due to mechanisms generating the migraine attacks or to the activation generated by the attacks. Potentially remediable risk factors for chronification include frequency of migraine attacks, obesity, excessive use of medications, caffeine overuse, stressful life events, depression, sleep disorders and cutaneous allodynia.

Entities: Chemical Disease

Mesh：

Year: 2010 PMID： 20464576 DOI： 10.1007/s10072-010-0264-y

Source DB: PubMed Journal: Neurol Sci ISSN： 1590-1874 Impact factor: 3.307

29 in total

Review 1. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy.

Authors: Jianren Mao
Journal: Pain Date: 2002-12 Impact factor: 6.961

Review 2. Risk factors for headache chronification.

Authors: Ann I Scher; Lynn A Midgette; Richard B Lipton
Journal: Headache Date: 2008-01 Impact factor: 5.887

Review 3. Borderline personality disorder and the chronic headache patient: review and management recommendations.

Authors: Joel R Saper; Alvin E Lake
Journal: Headache Date: 2002 Jul-Aug Impact factor: 5.887

4. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.

Authors: R Burstein; M F Cutrer; D Yarnitsky
Journal: Brain Date: 2000-08 Impact factor: 13.501

5. Improved identification of allodynic migraine patients using a questionnaire.

Authors: A Ashkenazi; S Silberstein; M Jakubowski; R Burstein
Journal: Cephalalgia Date: 2007-04 Impact factor: 6.292

6. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

Authors: K M Welch; V Nagesh; S K Aurora; N Gelman
Journal: Headache Date: 2001 Jul-Aug Impact factor: 5.887

7. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study.

Authors: J-A Zwart; G Dyb; K Hagen; S Svebak; J Holmen
Journal: Neurology Date: 2003-07-22 Impact factor: 9.910

8. Vanishing cerebellar infarcts in a migraine patient.

Authors: T D Rozen
Journal: Cephalalgia Date: 2007-06 Impact factor: 6.292

9. Migraine as a risk factor for subclinical brain lesions.

Authors: Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal: JAMA Date: 2004-01-28 Impact factor: 56.272

Review 10. Looking to the future: research designs for study of headache disease progression.

Authors: Richard B Lipton; Marcelo E Bigal
Journal: Headache Date: 2008-01 Impact factor: 5.887

10 in total

Review 1. Migrainomics - identifying brain and genetic markers of migraine.

Authors: Dale R Nyholt; David Borsook; Lyn R Griffiths
Journal: Nat Rev Neurol Date: 2017-11-17 Impact factor: 42.937

2. Correlation Between Life Events and Quality of Life in Patients with Medication-Overuse Headache.

Authors: Ebru Altintaş; Başak Karakurum Göksel; Nilgün Taşkintuna; Çağla Saritürk
Journal: Noro Psikiyatr Ars Date: 2015-07-07 Impact factor: 1.339

3. Cutaneous allodynia in patients with episodic migraine.

Authors: Hayat Güven; Aslı Ece Çilliler; Selim Selçuk Çomoğlu
Journal: Neurol Sci Date: 2012-11-23 Impact factor: 3.307

4. Stress in migraine: personality-dependent vulnerability, life events, and gender are of significance.

Authors: Kerstin Hedborg; Ulla Maria Anderberg; Carin Muhr
Journal: Ups J Med Sci Date: 2011-06-14 Impact factor: 2.384

5. Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.

Authors: Anja Bumb; Burkhard Seifert; Stephan Wetzel; Reto Agosti
Journal: Springerplus Date: 2013-08-10

6. The Rorschach Test Evaluation in Chronic Childhood Migraine: A Preliminary Multicenter Case-Control Study.

Authors: Maria Esposito; Antonietta Messina; Vincenzo Monda; Ilaria Bitetti; Filomena Salerno; Francesco Precenzano; Simone Pisano; Tiziana Salvati; Antonella Gritti; Rosa Marotta; Serena Marianna Lavano; Francesco Lavano; Agata Maltese; Lucia Parisi; Margherita Salerno; Gabriele Tripi; Beatrice Gallai; Michele Roccella; Domenico Bove; Maria Ruberto; Roberto Toraldo; Giovanni Messina; Marco Carotenuto
Journal: Front Neurol Date: 2017-12-12 Impact factor: 4.003

10. Instrumental assessment of physiotherapy and onabolulinumtoxin-A on cervical and headache parameters in chronic migraine.

Authors: Manuela Deodato; Antonio Granato; Caterina Borgino; Alessandra Galmonte; Paolo Manganotti
Journal: Neurol Sci Date: 2021-08-05 Impact factor: 3.307